JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3501
Protolabs
PRLB
$2.36B
| $677K | ﹤0.01% |
8,900
-2,533
| -22% | -$235K |
2016 Q2
15 quarters
|
|
3502
B&G Foods
BGS
$206M
| $676K | ﹤0.01% |
37,319
-54,605
| -59% | -$855K |
2013 Q2
27 quarters
|
|
3503
CALL
DuPont de Nemours
DD
$17.6B
| $675K | ﹤0.01% |
15,774
-16,799
| -52% | -$1.03M |
2018 Q2
7 quarters
|
|
3504
CALL
Itaú Unibanco
ITUB
$109B
| $674K | ﹤0.01% |
206,149
-309,224
| -60% | -$1.59M |
2017 Q4
9 quarters
|
|
3505
CNB Financial Corp
CCNE
$1.01B
| $672K | ﹤0.01% |
35,584
+11,233
| +46% | +$297K |
2017 Q4
9 quarters
|
|
3506
Syndax Pharmaceuticals
SNDX
$1.59B
| $672K | ﹤0.01% |
61,259
+14,324
| +31% | +$134K |
2016 Q4
13 quarters
|
|
|
FLY
3507
DELISTED
Fly Leasing Limited
FLY
| $671K | ﹤0.01% |
95,298
-43,521
| -31% | -$668K |
2018 Q2
7 quarters
|
|
3508
iShares MSCI Turkey ETF
TUR
$167M
| $670K | ﹤0.01% |
35,687
-35,827
| -50% | -$908K |
2015 Q1
20 quarters
|
|
3509
Metropolitan Bank Holding Corp
MCB
$1.1B
| $669K | ﹤0.01% |
24,852
+12,858
| +107% | +$535K |
2017 Q4
9 quarters
|
|
3510
Supernus Pharmaceuticals
SUPN
$2.49B
| $669K | ﹤0.01% |
37,199
-2,679
| -7% | -$56.3K |
2015 Q4
17 quarters
|
|
3511
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.82B
| $668K | ﹤0.01% |
+13,370
| New | +$672K |
2020 Q1
0 quarters
|
|
3512
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $668K | ﹤0.01% |
28,827
+7,364
| +34% | +$248K |
2016 Q4
13 quarters
|
|
3513
Goldman Sachs BDC
GSBD
$1.02B
| $667K | ﹤0.01% |
54,100
-1,500
| -3% | -$28.3K |
2017 Q1
12 quarters
|
|
3514
Nabors Industries
NBR
$1.26B
| $667K | ﹤0.01% |
34,181
+28,423
| +494% | +$2.6M |
2013 Q2
27 quarters
|
|
|
SP
3515
DELISTED
SP Plus Corporation
SP
| $665K | ﹤0.01% |
32,071
+21,581
| +206% | +$789K |
2017 Q4
9 quarters
|
|
3516
Covenant Logistics
CVLG
$842M
| $662K | ﹤0.01% |
152,944
-182,220
| -54% | -$1.14M |
2016 Q4
13 quarters
|
|
3517
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$570M
| $661K | ﹤0.01% |
27,984
-52,283
| -65% | -$1.53M |
2014 Q4
21 quarters
|
|
3518
Palomar
PLMR
$3.35B
| $661K | ﹤0.01% |
11,368
-20,138
| -64% | -$1.05M |
2019 Q2
3 quarters
|
|
3519
Alamos Gold
AGI
$13.5B
| $660K | ﹤0.01% |
131,989
+76,664
| +139% | +$450K |
2019 Q3
2 quarters
|
|
|
PNNT
3520
Pennant Park Investment Corp
PNNT
$211M
| $660K | ﹤0.01% |
254,868
+53,654
| +27% | +$297K |
2013 Q2
27 quarters
|
|
|
ALTA
3521
DELISTED
Altabancorp
ALTA
| $659K | ﹤0.01% |
34,029
+5,731
| +20% | +$143K |
2017 Q4
9 quarters
|
|
3522
CALL
FirstEnergy
FE
$25.3B
| $657K | ﹤0.01% |
16,400
-49,500
| -75% | -$2.3M |
2019 Q2
3 quarters
|
|
3523
Puma Biotechnology
PBYI
$499M
| $657K | ﹤0.01% |
77,794
-10,114
| -12% | -$98.3K |
2013 Q2
27 quarters
|
|
|
CYOU
3524
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $657K | ﹤0.01% |
61,395
-112,290
| -65% | -$1.18M |
2019 Q2
3 quarters
|
|
3525
Quince Therapeutics
QNCX
$28.6M
| $654K | ﹤0.01% |
72
+12
| +20% | +$118K |
2019 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.